The company is a high-tech enterprise with non-invasive neural control medical equipment. The company insists on independent research and development and technical public relations. The main business is clinical neurological diagnosis, brain disease diagnosis and rehabilitation, non-invasive neural control, cognitive neuroscience research, AI brain control and other major market segments. Provide full-line diagnosis and treatment products and technical solutions for difficult brain diseases such as brain degeneration, Parkinson's disease, depression, addiction and post-stroke rehabilitation. Its main customers are domestic medical institutions, universities, scientific research institutions and other enterprises.
In recent years, the government encourages the localization of medical devices, trying to change the status quo that high-end medical devices rely on imports. The TMS transcranial magnetic stimulation system independently developed and produced by Han Xiang Group has carried out strategic cooperation with Peking University Sixth Hospital, Shanghai Mental Health Center, Sichuan Huaxi Hospital, PLA Army General Hospital and Shenzhen People's Hospital. And actively participate in the promotion of national industry standards and clinical standardization, and continue to sell to the United States, Germany, Sweden, Italy, Australia and South Korea. "